Skip to main content
CriticalFDAfda-F-1844-2017LACERATION

Marketside Grab and Go Col. Sharp Cheddar 10.8 oz Set Ups

⚠ Critical Alert — Stop Using Immediately

This product has been flagged with severe risks (laceration). Stop using it now and contact the brand or FDA for a refund, repair, or replacement.

Category
Units Affected
12,328
Recall Date
February 15, 2017
Issuing Agency
Hazard
Laceration

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1844-2017.

The firm was notified by their supplier that various cheese products test positive for Listeria monocytogenes.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1844-2017.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Biery Cheese, Inc. or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1844-2017.

Biery Cheese, Inc.

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Biery Cheese, Inc. Recall FAQ

Biery Cheese, Inc. is the subject of a food safety report: Marketside Grab and Go Col. Sharp Cheddar 10.8 oz Set Ups. The notice was published on February 15, 2017 by the U.S. Food and Drug Administration (FDA). Approximately 12,328 units are potentially affected.